Bessemer Group Inc Boston Scientific Corp Transaction History

Bessemer Group Inc

  • $60.7 Billion
  • Q3 2024

A detailed history of Bessemer Group Inc transactions in Boston Scientific Corp stock. As of the latest transaction made, Bessemer Group Inc holds 23,712 shares of BSX stock, worth $2.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,712
Previous 18,089 31.09%
Holding current value
$2.15 Million
Previous $1.39 Million 42.74%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$72.96 - $84.0 $410,254 - $472,332
5,623 Added 31.09%
23,712 $1.99 Million
Q2 2024

Aug 13, 2024
BUY
$67.33 - $77.71 $71,639 - $82,683
1,064 Added 6.25%
18,089 $1.39 Million
Q1 2024

May 13, 2024
BUY
$57.6 - $68.62 $167,385 - $199,409
2,906 Added 20.58%
17,025 $1.17 Million
Q4 2023

Feb 09, 2024
SELL
$48.64 - $57.81 $211,000 - $250,779
-4,338 Reduced 23.5%
14,119 $817,000
Q3 2023

Nov 13, 2023
BUY
$50.19 - $54.68 $178,375 - $194,332
3,554 Added 23.85%
18,457 $975,000
Q2 2023

Aug 10, 2023
BUY
$49.72 - $54.64 $228,363 - $250,961
4,593 Added 44.55%
14,903 $806,000
Q1 2023

May 10, 2023
SELL
$45.09 - $50.03 $21,057 - $23,364
-467 Reduced 4.33%
10,310 $516,000
Q4 2022

Feb 13, 2023
SELL
$39.56 - $47.22 $49,252 - $58,788
-1,245 Reduced 10.36%
10,777 $499,000
Q3 2022

Nov 09, 2022
SELL
$36.71 - $109.66 $330,867 - $988,365
-9,013 Reduced 42.85%
12,022 $465,000
Q2 2022

Aug 10, 2022
BUY
$35.24 - $47.1 $20,756 - $27,741
589 Added 2.88%
21,035 $784,000
Q1 2022

May 12, 2022
BUY
$40.9 - $45.1 $492,149 - $542,688
12,033 Added 143.03%
20,446 $905,000
Q4 2021

Jan 27, 2022
BUY
$38.07 - $44.87 $37,270 - $43,927
979 Added 13.17%
8,413 $358,000
Q3 2021

Nov 12, 2021
SELL
$41.23 - $45.88 $122,576 - $136,401
-2,973 Reduced 28.57%
7,434 $322,000
Q2 2021

Aug 06, 2021
BUY
$38.58 - $44.24 $81,943 - $93,965
2,124 Added 25.64%
10,407 $444,000
Q1 2021

May 13, 2021
BUY
$35.27 - $39.67 $42,429 - $47,723
1,203 Added 16.99%
8,283 $320,000
Q4 2020

Feb 09, 2021
SELL
$33.15 - $41.97 $115 Million - $146 Million
-3,479,297 Reduced 99.8%
7,080 $255,000
Q3 2020

Nov 12, 2020
BUY
$34.44 - $42.23 $12.6 Million - $15.5 Million
367,132 Added 11.77%
3,486,377 $133 Million
Q2 2020

Aug 05, 2020
BUY
$30.19 - $39.11 $9.45 Million - $12.2 Million
312,986 Added 11.15%
3,119,245 $110 Million
Q1 2020

Apr 30, 2020
SELL
$25.83 - $45.71 $3.48 Million - $6.16 Million
-134,851 Reduced 4.59%
2,806,259 $91.6 Million
Q4 2019

Feb 04, 2020
SELL
$37.87 - $45.37 $53 Million - $63.5 Million
-1,398,517 Reduced 32.23%
2,941,110 $133 Million
Q3 2019

Nov 07, 2019
BUY
$40.31 - $43.45 $1.07 Million - $1.15 Million
26,495 Added 0.61%
4,339,627 $177 Million
Q2 2019

Jul 19, 2019
BUY
$34.91 - $42.98 $2.25 Million - $2.77 Million
64,394 Added 1.52%
4,313,132 $185 Million
Q1 2019

May 13, 2019
BUY
$32.91 - $40.75 $140 Million - $173 Million
4,244,722 Added 105695.27%
4,248,738 $163 Million
Q4 2018

Feb 12, 2019
BUY
$31.73 - $39.04 $51,846 - $63,791
1,634 Added 68.6%
4,016 $142,000
Q3 2018

Nov 06, 2018
SELL
$32.83 - $38.63 $17,793 - $20,937
-542 Reduced 18.54%
2,382 $92,000
Q2 2018

Jul 25, 2018
SELL
$26.84 - $34.32 $177,063 - $226,409
-6,597 Reduced 69.29%
2,924 $96,000
Q1 2018

May 10, 2018
SELL
$25.2 - $28.54 $19,328 - $21,890
-767 Reduced 7.46%
9,521 $260,000
Q4 2017

Jan 30, 2018
BUY
$24.79 - $29.8 $57,140 - $68,689
2,305 Added 28.87%
10,288 $255,000
Q3 2017

Nov 03, 2017
BUY
$26.26 - $29.17 $209,633 - $232,864
7,983
7,983 $233,000

Others Institutions Holding BSX

# of Institutions
1,542
Shares Held
1.19B
Call Options Held
6.79M
Put Options Held
10.1M
View Full List

About BOSTON SCIENTIFIC CORP

BSX Quotes by TradingView
  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email